Merck buying Twin Cities medtech firm Bio-Techne for $11.3B (opens in new tab)
The 50-year-old Bio-Techne was under activist pressure to sell, according to reports.
Read the original articleThe 50-year-old Bio-Techne was under activist pressure to sell, according to reports.
Read the original article